JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 24, 2004; DOI: 10.1124/jpet.103.062265


0022-3565/04/3093-1011-1019$20.00
JPET 309:1011-1019, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.062265v1
309/3/1011    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wehrwein, E. A.
Right arrow Articles by Watts, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wehrwein, E. A.
Right arrow Articles by Watts, S. W.

CARDIOVASCULAR

Rho/Rho Kinase and Phosphoinositide 3-Kinase Are Parallel Pathways in the Development of Spontaneous Arterial Tone in Deoxycorticosterone Acetate-Salt Hypertension

Erica A. Wehrwein, Carrie A. Northcott, Robert D. Loberg, and Stephanie W. Watts

Departments of Pharmacology and Toxicology (E.A.W., C.A.N., S.W.W.) and Physiology (E.A.W.), Michigan State University, East Lansing, Michigan; and Department of Physiology (R.D.L.), University of Michigan, Ann Arbor, Michigan

Hypertension is characterized by abnormal vascular contractility and function. Arteries from deoxycorticosterone acetate (DOCA)-salt hypertensive rats develop spontaneous tone that is not observed in arteries from normotensive rats. Inhibition of phosphoinositide 3-kinase (PI3-kinase) by 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) reduces spontaneous tone development. The Rho/Rho-kinase pathway has been suggested to play a role in hypertension and may be dependent on PI3-kinase activity. We hypothesized that Rhokinase is involved in spontaneous tone development and that Rho/Rho-kinase is a downstream effector of PI3-kinase. Using endothelium-denuded aortic strips in isolated tissue bath, we demonstrated that (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) (Y27632) (1 µM), a Rho-kinase inhibitor, significantly reduced spontaneous tone in the DOCA aorta but that it did not affect sham aorta basal tone (DOCA 63.5 ± 15.9 versus sham 1.2 ± 0.4 total change in percentage of phenylephrine contraction). We examined the interaction between the PI3-kinase and Rho pathways by observing the effects of LY294002 on a Rhokinase effector, myosin phosphatase (MYPT), and Y27632 on a PI3-kinase effector, Akt, using Western blot analysis. Inhibition of PI3-kinase reduced spontaneous tone, but it had no effect on the phosphorylation status of MYPT, indicating that PI3-kinase is not a downstream effector of Rho/Rho-kinase. These data indicate that there is little interaction between the Rho/Rhokinase and PI3-kinase pathways in the DOCA-salt aorta, and the two pathways seem to operate in parallel in supporting spontaneous arterial tone. These data reflect spontaneous tone only and do not rule out the possibility of interaction between these pathways in agonist-stimulated tone.


Received October 30, 2003; accepted February 24, 2004.

Address correspondence to: Dr. Stephanie W. Watts, Department of Pharmacology and Toxicology, B445 Life Science Bldg., Michigan State University, East Lansing, MI 48824-1317. E-mail: wattss{at}msu.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. J. Allahdadi, B. R. Walker, and N. L. Kanagy
ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2911 - H2918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. B. Atkins, A. Prezkop, J. L. Park, J. Saha, D. Duquaine, M. J. Charron, A. L. Olson, and F. C. Brosius 3rd
Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aorta
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H402 - H408.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells
Hypertension, October 1, 2006; 48(4): 534 - 540.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Teng, W. Qin, H. R. Ansari, and S. J. Mustafa
Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2574 - H2580.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. L. Lee, R. C. Webb, and L. Jin
Hypertension and RhoA/Rho-Kinase Signaling in the Vasculature: Highlights From the Recent Literature
Hypertension, December 1, 2004; 44(6): 796 - 799.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.